TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/16/20 18:58 | 12/15/20 | CERT | Certara, Inc. | DE | Tech | Softw | Prepackaged Software | Walsh Matthew M | NJ | D | P | 115 | 23.00 | 0 | 5 | 3 | 173 | D | |||||||||||||||
11/19/18 19:22 | 11/16/18 | AGN | Allergan Plc | L2 | Health | Drug | Pharmaceutical Preparations | Walsh Matthew M | L2 | O | EVP,CFO | P | 157 | 157.00 | 0 | 1 | 4 | 26 | D | ||||||||||||||
3/8/18 10:44 | 3/8/18 | AGN | Allergan Plc | L2 | Health | Drug | Pharmaceutical Preparations | Walsh Matthew M | L2 | O | EVP,CFO | P | 154 | 153.96 | 0 | 1 | 4 | 25 | D | ||||||||||||||
2/22/18 16:25 | 2/21/18 | AGN | Allergan Plc | L2 | Health | Drug | Pharmaceutical Preparations | Walsh Matthew M | L2 | O | EVP,CFO | P.d | 322 | 160.94 | 0 | 2 | 9 | 24 | D | ||||||||||||||
8/23/05 11:59 | 8/22/05 | GETI | Gentek Inc | DE | Auto | AutoPt | Motor Vehicle Parts & Accesso | Walsh Matthew M | NJ | O | VP,CFO,A | P | 3 | 13.75 | 0 | 0 | 3 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |